CJC-1295 with DAC in Growth Research requires traceable specification (5mg) and RUO acknowledgment; CJC-1295 with DAC Catalog Comparison Notes outlines buyer steps on sulanpeptide.vip.
CJC-1295 with DAC is a modified GHRH analog peptide used in laboratory research on growth-hormone-axis signaling, peptide half-life extension, and receptor-pathway studies involving DAC-mediated albumin binding.
Endocrine society abstracts and journal articles discuss prolonged GHRH analog exposure effects on pulsatile GH secretory pattern models in swine and rodent systems. CJC-1295 with DAC incorporates a Drug Affinity Complex (maleimidopropionyl linker) extending half-life in GHRH receptor binding studies.
Research compares DAC-modified GHRH(1-29) analogs against native GHRH pulses in pituitary somatotroph cell lines measuring GH secretagogue responses. GH release ELISA from primary pituitary cultures and GHRH receptor internalization microscopy are common assay endpoints.
Related Growth Research items include CJC-1295 (no DAC), CJC1295(no DAC)&IPA, HCG, HGH 191AA. Export spec fields before leadership approval. Single-peptide and blend formats serve different experimental designs; confirm protocol needs before selecting CJC-1295 with DAC.
Catalog comparison: Compare CJC-1295 with DAC (5mg) on vial format, documented purity, and COA access—not product name alone.
Catalog identifiers for CJC-1295 with DAC: CAS 446262-90-4, Formula: C165H269N47O46. MW 3647.25 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Listed formats for CJC-1295 with DAC: 5mg*10vials. Quote emails should include Cat No. (CD5) so delivered vials match protocol design.
When citing external effect sizes for CJC-1295 with DAC, match mg strength to published studies.
Price-per-mg comparisons for CJC-1295 with DAC should include documentation and shipping—not vial price alone.
Peer products in Growth Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for CJC-1295 with DAC. Catalog comparison for CJC-1295 with DAC within Growth Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs.
CJC-1295 with DAC (5mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials. Literature effect sizes for CJC-1295 with DAC experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names.
Price-per-mg analysis for CJC-1295 with DAC should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone.
Literature effect sizes for CJC-1295 with DAC experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names. Price-per-mg analysis for CJC-1295 with DAC should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone.
CJC-1295 with DAC (5mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials.
CJC-1295 with DAC from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.